Methods16, 1289–1296. https://doi.org/10.1038/s41592-019-0619-0 .https://www. ncbi.nlm.nih.gov/pubmed/31740819 . Kreiter, S., Vormehr, M., van de Roemer, N., Diken, M., Lower, M., Diekmann, J., Boegel, S., Schrors, B., Vascotto, F., Castle, J.C., et al. (2015). Mutant MHCclass II epitopes drive therapeutic immune responses to cancer. Nature 520, 692–696.